Abstract:Previous studies have suggested that microRNAs (miRNAs) may play important roles in tumorigenesis, but little is known about the functions of most miRNAs in cancer development. In the present study, we set up a cell-based screen using a luciferase reporter plasmid carrying the whole approximately 4.7 kb 3'-UTR of estrogen receptor alpha (ERalpha) mRNA cotransfected with a synthetic miRNA expression library to identify potential ERalpha-targeting miRNAs. Among all the miRNAs, miR-22 was found to repress robustly the luciferase signal in both HEK-293T and ERalpha-positive MCF-7 cells. Mutation of the target site was found to abrogate this repression effect of miR-22, whereas antagonism of endogenous miR-22 in MDA-MB-231 cells resulted in elevated reporter signals. We assessed the miR-22 expression patterns in five breast cancer cell lines and 23 clinical biopsies and revealed that there is a significant inverse association between the miR-22 levels and ERalpha protein expression. To evaluate the potential of miR-22 as a potential therapeutic intervention, we found that reduction of endogenous ERalpha protein levels and suppression of cancer cell growth could be achieved in MCF-7 cells by miR-22 overexpression in a way that can be recapitulated by the introduction of specific small interfering RNA against ERalpha. The phenomena can be rescued by the reintroduction of ERalpha. Taken together, our data indicate that miR-22 was frequently downregulated in ERalpha-positive human breast cancer cell lines and clinical samples. Direct involvement in the regulation of ERalpha may be one of the mechanisms through which miR-22 could play a pivotal role in the pathogenesis of breast cancer.

Stable Knockdown of Estrogen Receptor Alpha by Vector-Based Rna Interference Suppresses Proliferation and Enhances Apoptosis in Breast Cancer Cells

Overexpression of ERα Inhibits Proliferation and Invasion of MKN28 Gastric Cancer Cells by Suppressing Β-Catenin

Estrogen receptor β exhibited anti-tumor effects on osteosarcoma cells by regulating integrin, IAP, NF-kB/BCL-2 and PI3K/Akt signal pathway.

Role of Estrogen Receptor-Mediated Anti-Tumor Effects in U2OS Cells.

Estrogen-independent Effects of ER-α36 in ER-negative Breast Cancer

Stable Transfection of Estrogen Receptor-Alpha Suppresses Expression of Cyclooxygenase-2 and Vascular Endothelial Growth Factor-C in MDA-MB-231 Breast Cancer Cells.

The function of silence ER-α36 gene and its impact on MDA-MB-231 cells of estrogen receptor-negative breast cancer

Estrogen Receptor Α Variant ERα46 Mediates Growth Inhibition and Apoptosis of Human HT-29 Colon Adenocarcinoma Cells in the Presence of 17Β-Oestradiol

Proliferation suppression and apoptosis of ovarian carcinoma cells induced by small interfering RNA against vascular endothelial growth factor.

Inhibitory effect of ERα-targeted RNA interference on the growth of human breast cancer cell line Bcap-37

An Estrogen Receptor Α Suppressor, Microrna‐22, is Downregulated in Estrogen Receptor Α‐positive Human Breast Cancer Cell Lines and Clinical Samples

Estrogen receptor β1 induces apoptosis of MDA-MB-231 breast cancer cells by regulating the expression of Bax gene

Effects on Xenografts in Nude Mice of Estrogen Receptor Β Expression

Estrogen Receptor Α Mediates Proliferation of Breast Cancer MCF–7 Cells Via a P21/pcna/e2f1‐dependent Pathway

Estrogen-Induced Interaction Between Klf5 And Estrogen Receptor (Er) Suppresses The Function Of Er In Er-Positive Breast Cancer Cells

Study on the regulatory effect of estrogen receptor α on the invasion of endometrial carcinoma

Estrogen Receptor Α-Mediated Signaling Inhibits Type I Interferon Response to Promote Breast Carcinogenesis

Ribozyme-Mediated Cleavage of the Estrogen Receptor Messenger Rna and Inhibition of Receptor Function in Target Cells

Survivin Stable Knockdown by Sirna Inhibits Tumor Cell Growth and Angiogenesis in Breast and Cervical Cancers

Estrogen Receptor-Negative Breast Cancer Cells Transfected with Estrogen Receptor Exhibit Decreased Tumour Progression and Sensitivity to Growth Inhibition by Estrogen.

MicroRNA-22 Inhibits Proliferation, Invasion and Metastasis of Breast Cancer Cells Through Targeting Truncated Neurokinin-1 Receptor and ERα.